FDA Approves New Pancreatic Cancer Treatment

Why it matters locally: The approval of a new pancreatic cancer treatment by the FDA could offer new hope and options for the estimated 730 Alabamians diagnosed with pancreatic cancer each year, potentially improving patient outcomes across the state.

U.S. health officials approved a new drug for pancreatic cancer. The Food and Drug Administration (FDA) announced the approval, which introduces a different method for treating the illness. The drug functions by blocking a protein that contributes to tumor growth. This protein is present in most pancreatic cancer cases. The new treatment targets this specific mechanism.